These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9370937)

  • 1. Identification of specific recognition molecules on murine mononuclear phagocytes and B lymphocytes for Vi capsular polysaccharide: modulation of MHC class II expression on stimulation with the polysaccharide.
    Qadri A
    Immunology; 1997 Sep; 92(1):146-52. PubMed ID: 9370937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin transforms anti-inflammatory Salmonella typhi virulence polysaccharide into a TLR-2 agonist.
    Garg R; Qadri A
    J Immunol; 2010 Jun; 184(11):5980-7. PubMed ID: 20439919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vi capsular polysaccharide: Synthesis, virulence, and application.
    Hu X; Chen Z; Xiong K; Wang J; Rao X; Cong Y
    Crit Rev Microbiol; 2017 Aug; 43(4):440-452. PubMed ID: 27869515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vi Capsular Polysaccharide of Salmonella Typhi Promotes Macrophage Phagocytosis by Binding the Human C-Type Lectin DC-SIGN.
    Zhang LF; Lepenies B; Nakamae S; Young BM; Santos RL; Raffatellu M; Cobb BA; Hiyoshi H; Bäumler AJ
    mBio; 2022 Dec; 13(6):e0273322. PubMed ID: 36286551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between structure and immunologic properties of the Vi capsular polysaccharide.
    Szu SC; Li XR; Stone AL; Robbins JB
    Infect Immun; 1991 Dec; 59(12):4555-61. PubMed ID: 1937814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific and Cross-reactive Plasmablast Response in Humans after Primary and Secondary Immunization with Vi Capsular Polysaccharide Typhoid Vaccine.
    Pakkanen SH; Kantele JM; Rombo L; Kantele A
    Scand J Immunol; 2017 Oct; 86(4):207-215. PubMed ID: 28675263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal Regulation of OmpR and Hfq and Their Regulatory Actions on the Vi Polysaccharide Capsular Antigen in Salmonella enterica Serovar Typhi.
    Zhang Y; Xia L; Lin L; Tang H; Osei-Adjei G; Xu S; Zhang Y; Huang X
    Curr Microbiol; 2018 Jun; 75(6):773-778. PubMed ID: 29417203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against two discrete determinants on Vi capsular polysaccharide.
    Qadri A; Ghosh S; Talwar GP
    J Immunoassay; 1990; 11(2):235-50. PubMed ID: 1693381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of monoclonal antibodies to Vi polysaccharide antigen of Salmonella typhi.
    Pongsunk S; Sarasombath S; Ekpo P; Tangtherawattana P; Levine MM
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):53-6. PubMed ID: 8216560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with the conjugate vaccine Vi-CRM₁₉₇ against Salmonella typhi induces Vi-specific mucosal and systemic immune responses in mice.
    Fiorino F; Ciabattini A; Rondini S; Pozzi G; Martin LB; Medaglini D
    Vaccine; 2012 Sep; 30(43):6111-4. PubMed ID: 22705173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Vi Negative Isolates of Salmonella Enterica Serovar Typhi.
    Haque A
    Adv Exp Med Biol; 2018; 1052():9-18. PubMed ID: 29785477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhi.
    Liao J; Nickerson KG; Bystricky S; Robbins JB; Schneerson R; Szu SC; Kabat EA
    Infect Immun; 1995 Nov; 63(11):4429-32. PubMed ID: 7591081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi.
    Wilson RP; Winter SE; Spees AM; Winter MG; Nishimori JH; Sanchez JF; Nuccio SP; Crawford RW; Tükel Ç; Bäumler AJ
    Infect Immun; 2011 Feb; 79(2):830-7. PubMed ID: 21098104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
    Acharya IL; Lowe CU; Thapa R; Gurubacharya VL; Shrestha MB; Cadoz M; Schulz D; Armand J; Bryla DA; Trollfors B
    N Engl J Med; 1987 Oct; 317(18):1101-4. PubMed ID: 3657877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.
    Santander J; Wanda SY; Nickerson CA; Curtiss R
    Infect Immun; 2007 Mar; 75(3):1382-92. PubMed ID: 17178790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.